Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003176400 | SCV003855798 | pathogenic | Hereditary cancer-predisposing syndrome | 2022-11-01 | criteria provided, single submitter | clinical testing | The c.210_211ins11 variant, located in coding exon 1 of the MSH2 gene, results from an insertion of 11 nucleotides at position 210, causing a translational frameshift with a predicted alternate stop codon (p.G71Rfs*17). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |